📋 Tender Overview
Contract awarded for 2026/0448 - centralized aggregation for additional medications for the year 2026 lot-0008, title: eculizumab [300 mg; sol inj; frs], description: eculizumab [300 mg; sol inj; frs] lot-0009, title: eculizumab [300 mg; sol inj; frs], description: eculizumab [300 mg; sol inj; frs] estimated value excluding vat: 210150.40 eur.2026/0448 - centralized aggregation for additional medications for the year 2026
